Commercializing Industrial Biotechnology is a workshop where industrial biotech thought leaders share their experiences and their views on current challenges.
The number one asset of any R&D company is its data—if it is meaningful and trustworthy. Tim Gardner discusses a process-centric approach to creating and harnessing data with Riffyn Nexus & JMP.
Timothy Gardner will lead a breakout discussion on creating a digital backbone for biomanufacturing as part of the SynBioBeta Built with Biology Summit.
Join us for an expert panel hosted by JMP Statistically Speaking on 23 June. The panelists will discuss how design of experiments can transform the way we innovate.
At this event in collaboration with Synbiobeta, we will bring together leaders in the field of synthetic biology to discuss how we can re-imagine R+D, digitalization, and manufacturing.